Healthcare Industry News: ultrasound
News Release - June 5, 2015
Largest Outpatient Imaging Center in the U.S. Installs First Toshiba Celesteion PET/CT SystemSteinberg Diagnostic Improves Patient Care and Establishes Local Leadership in Molecular Imaging
TUSTIN, Calif.--(Healthcare Sales & Marketing Network)--One of the few PET/CT capable imaging facilities in the Las Vegas area, Steinberg Diagnostic Medical Imaging (SDMI) has bolstered its capabilities by installing the first CelesteionTM PET/CT system in the U.S. from Toshiba America Medical Systems, Inc. The premier system in PET/CT, the Celesteion allows SDMI to provide the highest quality images and exams without sacrificing patient comfort.
“With the Celesteion, we found a wide-bore system that let us scan a variety of patients comfortably, as well as being a more-than-capable planning device for both PET and CT radiation therapy,” said Dr. Mark Winkler, professor of health sciences at the University of Nevada, Las Vegas and founding partner of SDMI. “It’s become the preferred system among our patients, as well as giving us the long term outlook of more referrals with the increase in oncological offerings.”
The Celesteion is designed with the patient in mind, with features that include:
- Industry’s largest bore – Offering a feeling of openness and versatile patient positioning
- Fast and accurate diagnoses – Accurate lesion detection with time of flight technology and a 70 cm PET and CT field-of-view
- System versatility – A total cost-of-ownership solution, the Celesteion can perform diagnostic CT imaging, CT interventions, PET/CT imaging and CT radiation oncology simulation scans
- CT dose reduction – Ensuring patient safety is not a choice, Celesteion comes standard with Toshiba’s most advanced CT dose reduction technology, AIDR 3D, and conforms to the requirements of MITA’s XR-29 Smart Dose Standard
Toshiba will showcase the Celesteion PET/CT system at this year’s Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting in Baltimore, June 6-10, 2015 (Booth #125).
About Toshiba America Medical Systems, Inc.
With headquarters in Tustin, Calif., Toshiba America Medical Systems markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and cardiovascular equipment, and coordinates clinical diagnostic imaging research for all modalities in the United States. For more information, visit Toshiba’s website at www.medical.toshiba.com.
About Toshiba Medical Systems Corporation
Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba. Visit Toshiba Medical Systems Corporation’s website at www.toshibamedicalsystems.com.
Toshiba Corporation, a Fortune 500 company, channels world-class capabilities in advanced electronic and electrical products and systems into five strategic business domains: Energy & Infrastructure, Community Solutions, Healthcare Systems & Services, Electronic Devices & Components, and Lifestyles Products & Services. Guided by the principles of The Basic Commitment of the Toshiba Group, “Committed to People, Committed to the Future,” Toshiba promotes global operations towards securing “Growth Through Creativity and Innovation” and is contributing to the achievement of a world in which people everywhere live in a safe, secure and comfortable society.
Founded in Tokyo in 1875, today’s Toshiba is at the heart of a global network of over 590 consolidated companies employing over 200,000 people worldwide, with annual sales surpassing 6.5 trillion yen (US$63 billion). To find out more about Toshiba, visit www.toshiba.co.jp/index.htm.
Source: Toshiba America Medical Systems
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.